norcantharidin has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YJ; Ho, LT; Kuo, CD; Liao, HF; Liu, TY; Shieh, CJ; Tsai, TH | 1 |
| Chen, YJ; Kuo, CD; Liao, HF; Tsai, YM; Wang, GS; Yu, CC | 1 |
2 other study(ies) available for norcantharidin and Adenocarcinoma
| Article | Year |
|---|---|
Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Colorectal Neoplasms; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Tumor Cells, Cultured | 2005 |
Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Topics: Adenocarcinoma; Animals; Anoikis; Antimetabolites; Antineoplastic Agents; Blotting, Western; Bone Marrow Cells; Bridged Bicyclo Compounds, Heterocyclic; Bromodeoxyuridine; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Data Interpretation, Statistical; Enzyme Activation; Flow Cytometry; JNK Mitogen-Activated Protein Kinases; Mice; Monocytes | 2008 |